XML 17 R6.htm IDEA: XBRL DOCUMENT v3.5.0.2
CONDENSED STATEMENTS OF CASH FLOWS - USD ($)
3 Months Ended
Jun. 30, 2016
Jun. 30, 2015
Cash flows from operating activities:    
Net Income (loss) $ 11,122 $ 5,814,790
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities    
Share of Income from Operating Partnerships (147,623) (5,850,728)
Changes in assets and liabilities    
(Decrease) Increase in accounts payable and accrued expenses (5,154) 17,800
Decrease in other assets 0 2,200
(Decrease) Increase in accounts payable affiliates 76,152 38,584
Net cash (used in) provided by operating activities (65,503) 22,646
Cash flows from investing activities:    
Proceeds from the disposition of Operating Partnerships 97,615 [1] 6,192,561 [2]
Net cash provided by investing activities 97,615 6,192,561
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS 32,112 6,215,207
Cash and cash equivalents, beginning 1,783,433 2,523,234
Cash and cash equivalents, ending 1,815,545 8,738,441
Series Fifteen [Member]    
Cash flows from operating activities:    
Net Income (loss) (14,557) 374,504
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities    
Share of Income from Operating Partnerships 0 (325,769)
Changes in assets and liabilities    
(Decrease) Increase in accounts payable and accrued expenses (6,498) 3,000
Decrease in other assets 0 0
(Decrease) Increase in accounts payable affiliates 9,027 19,131
Net cash (used in) provided by operating activities (12,028) 70,866
Cash flows from investing activities:    
Proceeds from the disposition of Operating Partnerships 0 [1] 325,769 [2]
Net cash provided by investing activities 0 325,769
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS (12,028) 396,635
Cash and cash equivalents, beginning 116,858 414,859
Cash and cash equivalents, ending 104,830 811,494
Series Sixteen [Member]    
Cash flows from operating activities:    
Net Income (loss) 104,570 (48,500)
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities    
Share of Income from Operating Partnerships (147,623) 0
Changes in assets and liabilities    
(Decrease) Increase in accounts payable and accrued expenses 20,841 0
Decrease in other assets 0 0
(Decrease) Increase in accounts payable affiliates 43,221 45,774
Net cash (used in) provided by operating activities 21,009 (2,726)
Cash flows from investing activities:    
Proceeds from the disposition of Operating Partnerships 97,615 [1] 0 [2]
Net cash provided by investing activities 97,615 0
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS 118,624 (2,726)
Cash and cash equivalents, beginning 381,450 221,108
Cash and cash equivalents, ending 500,074 218,382
Series Seventeen [Member]    
Cash flows from operating activities:    
Net Income (loss) (25,440) 5,534,374
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities    
Share of Income from Operating Partnerships 0 (5,524,959)
Changes in assets and liabilities    
(Decrease) Increase in accounts payable and accrued expenses (6,499) 14,800
Decrease in other assets 0 2,200
(Decrease) Increase in accounts payable affiliates 0 (50,225)
Net cash (used in) provided by operating activities (31,939) (23,810)
Cash flows from investing activities:    
Proceeds from the disposition of Operating Partnerships 0 [1] 5,524,959 [2]
Net cash provided by investing activities 0 5,524,959
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS (31,939) 5,501,149
Cash and cash equivalents, beginning 640,398 197,779
Cash and cash equivalents, ending 608,459 5,698,928
Series Eighteen [Member]    
Cash flows from operating activities:    
Net Income (loss) (33,700) (31,312)
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities    
Share of Income from Operating Partnerships 0 0
Changes in assets and liabilities    
(Decrease) Increase in accounts payable and accrued expenses (6,499) 0
Decrease in other assets 0 0
(Decrease) Increase in accounts payable affiliates 23,904 23,904
Net cash (used in) provided by operating activities (16,295) (7,408)
Cash flows from investing activities:    
Proceeds from the disposition of Operating Partnerships 0 [1] 341,833 [2]
Net cash provided by investing activities 0 341,833
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS (16,295) 334,425
Cash and cash equivalents, beginning 353,832 306,518
Cash and cash equivalents, ending 337,537 640,943
Series Nineteen [Member]    
Cash flows from operating activities:    
Net Income (loss) (19,751) (14,276)
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities    
Share of Income from Operating Partnerships 0 0
Changes in assets and liabilities    
(Decrease) Increase in accounts payable and accrued expenses (6,499) 0
Decrease in other assets 0 0
(Decrease) Increase in accounts payable affiliates 0 0
Net cash (used in) provided by operating activities (26,250) (14,276)
Cash flows from investing activities:    
Proceeds from the disposition of Operating Partnerships 0 [1] 0 [2]
Net cash provided by investing activities 0 0
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS (26,250) (14,276)
Cash and cash equivalents, beginning 290,895 1,382,970
Cash and cash equivalents, ending $ 264,645 $ 1,368,694
[1] Fund proceeds from disposition does not include $50,008 which was due to a writeoff of capital contribution payable in Series 16.
[2] Fund proceeds from disposition include $341,833 which was receivable as of March 31, 2015 for Series 18.